Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2025-12-24 @ 11:16 PM
NCT ID:
NCT00843856
Eligibility Criteria:
Inclusion Criteria:
* Idiopathic membranous glomerulonephritis on renal biopsy
* Proteinuria - protein/creatinine ratio (PCR) \> 100 units with hypoalbuminaemia or PCR \> 300 units with normal serum albumin despite 3 months treatment with maximum tolerated doses of ace inhibitors and angiotensin 2 antagonists (or shorter if life threatening complications of nephrotic syndrome require institution of immediate immunosuppression)
* Male or female patients aged 18 to 80 years
Exclusion Criteria:
* Hepatitis B hepatitis C or HIV positive
* Malignancy (all patients must have a CT chest abdomen and pelvis and other investigations if clinically indicated)
* Untreated infection
* Females who are pregnant, breast feeding, or at risk of pregnancy and not using a medically acceptable form of contraception
* Any condition judged by the investigator that would cause the study to be detrimental to the patient
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT00843856
Study Brief:
Protocol Section:
NCT00843856